Listed

Boston Scientific Corp: Form 10-Q for the period ended Sep 30, 2022

Filed with the SEC on Nov 3, 2022 and accepted by EDGAR at Nov 3, 2022, 16:13 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-07-01 to 2022-09-30$3.17bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2022-01-01 to 2022-09-30$9.44bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-07-01 to 2022-09-30$979.0mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2022-01-01 to 2022-09-30$2.94bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2022-07-01 to 2022-09-30$2.19bnus-gaap:GrossProfit
Gross profit9 months2022-01-01 to 2022-09-30$6.50bnus-gaap:GrossProfit
Selling, general and administrative3 months2022-07-01 to 2022-09-30$1.13bnus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2022-01-01 to 2022-09-30$3.36bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-07-01 to 2022-09-30$358.0mus-gaap:OperatingIncomeLoss
Operating income9 months2022-01-01 to 2022-09-30$1.25bnus-gaap:OperatingIncomeLoss
Interest expense3 months2022-07-01 to 2022-09-30$63.0mus-gaap:InterestExpense
Interest expense9 months2022-01-01 to 2022-09-30$406.0mus-gaap:InterestExpense
Income tax3 months2022-07-01 to 2022-09-30$57.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2022-01-01 to 2022-09-30$188.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-07-01 to 2022-09-30$188.0mus-gaap:ProfitLoss
Net income9 months2022-01-01 to 2022-09-30$558.0mus-gaap:ProfitLoss
Diluted EPS3 months2022-07-01 to 2022-09-30$0.12us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2022-01-01 to 2022-09-30$0.36us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-07-01 to 2022-09-30$0.12us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-01-01 to 2022-09-30$0.36us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-07-01 to 2022-09-301,440,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2022-01-01 to 2022-09-301,438,700,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2022-01-01 to 2022-09-30$719.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2022-01-01 to 2022-09-30$376.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2022-01-01 to 2022-09-30$42.0mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2022-09-30$338.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-09-30$5.14bnus-gaap:AssetsCurrent
Total assetsAt period end2022-09-30$31.95bnus-gaap:Assets
Current liabilitiesAt period end2022-09-30$3.55bnus-gaap:LiabilitiesCurrent
Current portion of debtAt period end2022-09-30$20.0mus-gaap:DebtCurrent

Source: SEC EDGAR, the filing index for accession 0000885725-22-000028. Last ingested by Listed: Nov 6, 2026, 17:38 ET. Listed shows no prices and gives no investment advice.